BELLUS Health Inc. (BLU)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 09:46AM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 981.71M |
| Enterprise value | 748.59M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 50.19k |
| Price/book (mrq) | 3.55 |
| Enterprise value/revenue | 46.79k |
| Enterprise value/EBITDA | -10.73 |
Trading information
Stock price history
| Beta (5Y monthly) | -0.49 |
| 52-week change 3 | 268.47% |
| S&P500 52-week change 3 | -11.01% |
| 52-week high 3 | 11.10 |
| 52-week low 3 | 2.60 |
| 50-day moving average 3 | 8.32 |
| 200-day moving average 3 | 7.09 |
Share statistics
| Avg vol (3-month) 3 | 917.41k |
| Avg vol (10-day) 3 | 1.27M |
| Shares outstanding 5 | 106.75M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 61.42M |
| % held by insiders 1 | 11.27% |
| % held by institutions 1 | 88.92% |
| Shares short (14 June 2022) 4 | 12.75M |
| Short ratio (14 June 2022) 4 | 18.76 |
| Short % of float (14 June 2022) 4 | N/A |
| Short % of shares outstanding (14 June 2022) 4 | 11.94% |
| Shares short (prior month 12 May 2022) 4 | 11.98M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 18 Aug 2019 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 277:1000 |
| Last split date 3 | 18 Aug 2019 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 30 Mar 2022 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -454,187.50% |
Management effectiveness
| Return on assets (ttm) | -20.90% |
| Return on equity (ttm) | -33.82% |
Income statement
| Revenue (ttm) | 16k |
| Revenue per share (ttm) | 0.00 |
| Quarterly revenue growth (yoy) | 0.00% |
| Gross profit (ttm) | 16k |
| EBITDA | N/A |
| Net income avi to common (ttm) | -69.83M |
| Diluted EPS (ttm) | -0.81 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 233.97M |
| Total cash per share (mrq) | 2.19 |
| Total debt (mrq) | 845k |
| Total debt/equity (mrq) | 0.30 |
| Current ratio (mrq) | 15.33 |
| Book value per share (mrq) | 2.62 |
Cash flow statement
| Operating cash flow (ttm) | -60.13M |
| Levered free cash flow (ttm) | -31.8M |
© 2022 Yahoo. All rights reserved.
